-
1.发明申请Scd4ol and placental growth factor (plgf) used as a biochemical marker combination in cardiovascular diseases 有权Scd4ol和胎盘生长因子（plgf）用作心血管疾病中的生物化学标记物组合公开(公告)号：US20070042438A1
公开(公告)日：2007-02-22
申请号：US10534985
申请日：2003-11-10
IPC分类号： G01N33/53
CPC分类号： G01N33/6893 , C07K14/70575 , G01N2333/96486 , G01N2800/32
摘要： The invention relates to novel markers of vascular inflammation and combinations thereof as diagnostic and prognostic tools in patients with cardiovascular diseases. The markers also act as tools that facilitate the selection of active ingredients for the treatment of such diseases, and finally act as starting points for the treatment of cardiovascular diseases. Furthermore, the invention relates to the creation of an individual risk profile of negative events that are associated with the progression of arteriosclerosis.
摘要翻译： 本发明涉及血管炎症的新型标志物及其组合作为心血管疾病患者的诊断和预后工具。 标记物也作为促进活性成分选择用于治疗这些疾病的工具，最终成为治疗心血管疾病的起点。 此外，本发明涉及创建与动脉硬化进展相关的阴性事件的个体风险特征。
-
2.发明授权sCD40L and placental growth factor (PLGF) as biochemical marker combinations in cardiovascular diseases 有权sCD40L和胎盘生长因子（PLGF）作为心血管疾病的生物化学标记物组合公开(公告)号：US08673581B2
公开(公告)日：2014-03-18
申请号：US13613010
申请日：2012-09-13
CPC分类号： G01N33/6893 , C07K14/70575 , G01N2333/96486 , G01N2800/32
摘要： The invention relates to novel markers of vascular inflammation and combinations thereof as diagnostic and prognostic tools in patients with cardiovascular diseases. The markers also act as tools that facilitate the selection of active ingredients for the treatment of such diseases, and finally act as starting points for the treatment of cardiovascular diseases. Furthermore, the invention relates to the creation of an individual risk profile of negative events that are associated with the progression of arteriosclerosis.
摘要翻译： 本发明涉及血管炎症的新型标志物及其组合作为心血管疾病患者的诊断和预后工具。 标记物也作为促进活性成分选择用于治疗这些疾病的工具，最终成为治疗心血管疾病的起点。 此外，本发明涉及创建与动脉硬化进展相关的阴性事件的个体风险特征。
-
3.发明授权sCD40L and placental growth factor (PLGF) used as a biochemical marker combination in cardiovascular diseases 有权sCD40L和胎盘生长因子（PLGF）用作心血管疾病中的生物化学标记物组合公开(公告)号：US08409815B2
公开(公告)日：2013-04-02
申请号：US10534985
申请日：2003-11-10
CPC分类号： G01N33/6893 , C07K14/70575 , G01N2333/96486 , G01N2800/32
摘要： The invention relates to novel markers of vascular inflammation and combinations thereof as diagnostic and prognostic tools in patients with cardiovascular diseases. The markers also act as tools that facilitate the selection of active ingredients for the treatment of such diseases, and finally act as starting points for the treatment of cardiovascular diseases. Furthermore, the invention relates to the creation of an individual risk profile of negative events that are associated with the progression of arteriosclerosis.
摘要翻译： 本发明涉及血管炎症的新型标志物及其组合作为心血管疾病患者的诊断和预后工具。 标记物也作为促进活性成分选择用于治疗这些疾病的工具，最终成为治疗心血管疾病的起点。 此外，本发明涉及创建与动脉硬化进展相关的阴性事件的个体风险特征。
-
4.发明申请SCD40L AND PLACENTAL GROWTH FACTOR (PIGF) AS BIOCHEMICAL MARKER COMBINATIONS IN CARDIOVASCULAR DISEASES 有权SCD40L和PLACENTAL GROWTH FACTOR（PIGF）作为生物化学标记物在心血管疾病中的组合公开(公告)号：US20130004487A1
公开(公告)日：2013-01-03
申请号：US13613010
申请日：2012-09-13
IPC分类号： G01N33/53 , A61P9/00 , A61K39/395
CPC分类号： G01N33/6893 , C07K14/70575 , G01N2333/96486 , G01N2800/32
摘要： The invention relates to novel markers of vascular inflammation and combinations thereof as diagnostic and prognostic tools in patients with cardiovascular diseases. The markers also act as tools that facilitate the selection of active ingredients for the treatment of such diseases, and finally act as starting points for the treatment of cardiovascular diseases. Furthermore, the invention relates to the creation of an individual risk profile of negative events that are associated with the progression of arteriosclerosis.
摘要翻译： 本发明涉及血管炎症的新型标志物及其组合作为心血管疾病患者的诊断和预后工具。 标记物也作为促进活性成分选择用于治疗这些疾病的工具，最终成为治疗心血管疾病的起点。 此外，本发明涉及创建与动脉硬化进展相关的阴性事件的个体风险特征。
-
5.发明申请公开(公告)号：US20100173321A1
公开(公告)日：2010-07-08
申请号：US10437651
申请日：2003-05-14
申请人： Christian Hamm , Eberhard Spanuth
发明人： Christian Hamm , Eberhard Spanuth
IPC分类号： G01N33/53 , G01N33/566
CPC分类号： G01N33/6893 , G01N33/6887 , G01N2333/4712 , G01N2333/4737 , G01N2333/54 , G01N2333/5412 , G01N2333/58 , G01N2333/70503 , G01N2333/70525 , G01N2800/324
摘要： The present invention concerns methods for diagnosing myocardial infarction, for performing risk stratification of myocardial infarction, for making a prognosis of a disease course in a myocardial infarction patient, for identifying a patient with elevated risk of myocardial infarction, or combinations thereof, wherein a determination of at least three markers is performed on a patient sample. Furthermore, kits for performing the methods are provided.
摘要翻译： 本发明涉及用于诊断心肌梗死的方法，用于进行心肌梗死的风险分层，用于对心肌梗塞患者的疾病进程进行预后，以识别心肌梗死风险升高的患者或其组合，其中确定 对患者样品进行至少三个标记。 此外，提供了用于执行方法的套件。
-
6.发明授权Making a prognosis in cases of cardiac disease using a combination of markers 有权使用标记物的组合在心脏疾病的情况下预后公开(公告)号：US07790397B2
公开(公告)日：2010-09-07
申请号：US10437651
申请日：2003-05-14
申请人： Christian Hamm , Eberhard Spanuth
发明人： Christian Hamm , Eberhard Spanuth
IPC分类号： G01N33/53
CPC分类号： G01N33/6893 , G01N33/6887 , G01N2333/4712 , G01N2333/4737 , G01N2333/54 , G01N2333/5412 , G01N2333/58 , G01N2333/70503 , G01N2333/70525 , G01N2800/324
摘要： The present invention concerns methods for diagnosing myocardial infarction, for performing risk stratification of myocardial infarction, for making a prognosis of a disease course in a myocardial infarction patient, for identifying a patient with elevated risk of myocardial infarction, or combinations thereof, wherein a determination of at least three markers is performed on a patient sample. Furthermore, kits for performing the methods are provided.
摘要翻译： 本发明涉及用于诊断心肌梗死的方法，用于进行心肌梗死的风险分层，用于对心肌梗塞患者的疾病进程进行预后，以识别心肌梗死风险升高的患者或其组合，其中确定 对患者样品进行至少三个标记。 此外，提供了用于执行方法的套件。
-
-
-
-
-
搜索结果
6 条记录 (耗时 0.022 秒)
